Your browser doesn't support javascript.
loading
Donepezil, an anti-Alzheimer's disease drug, promotes differentiation and regeneration in injured skeletal muscle through the elevation of the expression of myogenic regulatory factors.
Todaka, Hiroshi; Arikawa, Mikihiko; Noguchi, Tatsuya; Ichikawa, Atsushi; Sato, Takayuki.
Affiliation
  • Todaka H; Department of Cardiovascular Control, Kochi Medical School, Nankoku, Kochi, Japan. Electronic address: htodaka@kochi-u.ac.jp.
  • Arikawa M; Department of Biological Sciences, Faculty of Science and Technology, Kochi University, Akebono, Kochi, Japan.
  • Noguchi T; Department of Cardiology and Geriatrics, Kochi Medical School, Nankoku, Kochi, Japan.
  • Ichikawa A; Department of Cardiovascular Control, Kochi Medical School, Nankoku, Kochi, Japan.
  • Sato T; Department of Cardiovascular Control, Kochi Medical School, Nankoku, Kochi, Japan.
Eur J Pharmacol ; 911: 174528, 2021 Nov 15.
Article in En | MEDLINE | ID: mdl-34582845
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Donepezil Type of study: Prognostic_studies Language: En Journal: Eur J Pharmacol Year: 2021 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Donepezil Type of study: Prognostic_studies Language: En Journal: Eur J Pharmacol Year: 2021 Document type: Article Country of publication: Netherlands